Payden & Rygel’s Novartis NVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-876	Closed	-$83K	–	145
2020 Q4	$83K	Hold	876	–	–	﹤0.01%	119
2020 Q3	$76K	Hold	876	–	–	﹤0.01%	109
2020 Q2	$77K	Hold	876	–	–	﹤0.01%	100
2020 Q1	$72K	Hold	876	–	–	0.01%	100
2019 Q4	$83K	Hold	876	–	–	0.01%	106
2019 Q3	$76K	Hold	876	–	–	0.01%	104
2019 Q2	$80K	Sell	876 -102	-10%	-$9.32K	0.01%	102
2019 Q1	$84K	Hold	978	–	–	0.01%	100
2018 Q4	$75K	Hold	978	–	–	0.01%	102
2018 Q3	$75K	Hold	978	–	–	0.01%	101
2018 Q2	$66K	Hold	978	–	–	0.01%	101
2018 Q1	$71K	Hold	978	–	–	0.01%	101
2017 Q4	$74K	Hold	978	–	–	0.01%	100
2017 Q3	$75K	Hold	978	–	–	0.01%	100
2017 Q2	$73K	Hold	978	–	–	0.01%	93
2017 Q1	$65K	Hold	978	–	–	0.01%	96
2016 Q4	$64K	Hold	978	–	–	0.01%	94
2016 Q3	$69K	Hold	978	–	–	0.01%	88
2016 Q2	$72K	Hold	978	–	–	0.01%	86
2016 Q1	$63K	Sell	978 -138	-12%	-$8.89K	0.01%	95
2015 Q4	$86K	Buy	1,116 +138	+14%	+$10.6K	0.01%	95
2015 Q3	$81K	Hold	978	–	–	0.01%	94
2015 Q2	$86K	Hold	978	–	–	0.01%	97
2015 Q1	$86K	Hold	978	–	–	0.01%	101
2014 Q4	$81K	Hold	978	–	–	0.02%	95
2014 Q3	$82K	Sell	978 -669	-41%	-$56.1K	0.02%	97
2014 Q2	$134K	Hold	1,647	–	–	0.03%	84
2014 Q1	$125K	Hold	1,647	–	–	0.05%	79
2013 Q4	$119K	Hold	1,647	–	–	0.04%	108
2013 Q3	$113K	Hold	1,647	–	–	0.04%	105
2013 Q2	$104K	Buy	+1,647	New	+$104K	0.04%	105